Skip to Content

IQVIA Holdings Inc IQV Stock Quote

| Rating as of


Last close prices updated as of Jan 27, 2023, 4:10 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 228.52
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Investment Style Large Blend
  • Day Range 226.59  –  230.86
  • Year Range 165.75  –  256.62
  • Market Cap 42.6218 Bil
  • Volume / Avg 616,440.0 /  962,470.7
  • Price / Sales 3.07
  • Price / Book 7.94
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis IQV

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Narrow-Moat IQVIA Faces Some Near-Term Macro Disruptions, but Positive Overall Outlook

Rachel Elfman Equity Analyst

Business Strategy and Outlook

| Rachel Elfman |

IQVIA (formerly QuintilesIMS) is the result of the merger of Quintiles, a leading late-stage contract research organization, or CRO, and IMS Health, a dominant player in life sciences data and analytics. The combined company has become an established leader among CROs and in the life sciences data and analytics space. Further, as a result of the merger, the company leads in real-world evidence, in which data from sources such as patient records or medical claims can be used to create clinical evidence for regulatory approval.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics IQV

Company Profile IQV

Business Description

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

4820 Emperor Boulevard
Durham, NC, 27703
Industry Diagnostics & Research
Employees 85,000

Related Articles IQV

FAQs for IQVIA Holdings Inc Stock

No. IQV does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

IQV’s market cap is 42.62 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

IQV’s stock style is Large Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

IQV’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare IQV’s historical performance against its industry peers and the overall market.